Skip to main content
NEUP
NASDAQ Life Sciences

Neuphoria Therapeutics Confirms Acquisition Discussions with Scancell

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$4.59
Mkt Cap
$24.699M
52W Low
$3.645
52W High
$21.4
52W Position info
26% above low
Off High info
79% below high
Rel. Volume info
3.7× avg
Market data snapshot near publication time

NEUP sits 26% above its 52-week low of $3.645 on elevated volume (3.7× avg).

Summary

Neuphoria Therapeutics confirmed it is in discussions regarding a potential acquisition by Scancell. This highly material development follows a significant Phase 3 trial setback for its BNC210 drug in May, which had negatively impacted the company. An acquisition could offer a substantial premium for shareholders and a strategic path forward, with Scancell potentially becoming NASDAQ-listed through the transaction. Investors will now focus on any further updates regarding these ongoing discussions.

At the time of this announcement, NEUP was trading at $4.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $24.7M. The 52-week trading range was $3.65 to $21.40. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

NEUP - Latest Insights

NEUP
Sep 18, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.70
Real-time Price: $2.32 info
Change: -$1.38 (-37%) info
Market Cap: $12.554M info
NEUP
Jul 23, 2026, 6:39 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $3.73
Real-time Price: $2.32 info
Change: -$1.41 (-38%) info
Market Cap: $12.554M info
NEUP
Jul 23, 2026, 6:37 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.73
Real-time Price: $2.32 info
Change: -$1.41 (-38%) info
Market Cap: $12.554M info
NEUP
Jul 23, 2026, 6:13 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $3.98
Real-time Price: $2.32 info
Change: -$1.66 (-42%) info
Market Cap: $12.554M info
NEUP
May 26, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.46
Real-time Price: $2.32 info
Change: -$3.14 (-58%) info
Market Cap: $12.554M info